Production of viable cells of gdhA derivative Pasteurella multocida B:2 for use as animal vaccine

The attenuated strain of gdhA derivative Pasteurella multocida B:2 (mutant) has demonstrated its efficacy as a live vaccine to control haemorrhagic septicaemia (HS) disease in cattle and buffaloes. However, the commercial application of this vaccine to control HS still faces some limitations such...

Full description

Bibliographic Details
Main Author: Oslan, Siti Nur Hazwani
Format: Thesis
Language:English
Published: 2017
Subjects:
Online Access:http://psasir.upm.edu.my/id/eprint/68527/1/FBSB%202018%2014%20IR.pdf
_version_ 1796978752427655168
author Oslan, Siti Nur Hazwani
author_facet Oslan, Siti Nur Hazwani
author_sort Oslan, Siti Nur Hazwani
collection UPM
description The attenuated strain of gdhA derivative Pasteurella multocida B:2 (mutant) has demonstrated its efficacy as a live vaccine to control haemorrhagic septicaemia (HS) disease in cattle and buffaloes. However, the commercial application of this vaccine to control HS still faces some limitations such as cost effectiveness of large scale cultivation process, low cell viability and productivity, and unsuitable commercial formulation in order to sustain the cell viability of the bacterial cells in live vaccine. The main objective of this study are to develop the bioprocessing method to increase viability in terms of productivity of gdhA derivative P. multocida B:2 with minimum production cost and to develop essential formulation in powderised form with high bacterial cell survival rate for subsequent use as animal live cell vaccine. The growth medium with the addition of histidine at a concentration of 20 mM greatly improved the cell viability of P. multocida B:2 mutant in cultivation using YDB as basal medium. During batch cultivation of this mutant, ammonium accumulated in the culture greatly inhibited the growth that reduced the final cell concentration and yield. The possibility of using cation-exchange resin for in situ removal of ammonium accumulated in the culture for the improvement of the cultivation of this mutant was investigated in this study. The ability of cationexchange resins, which included Amberlite IRC-86, Amberlite IR120 H, and Dowex DRG8 H, to selectively adsorbed ammonium was first investigated. Amberlite IRC-86, which has capability on ammonium adsorption with Qmax value of 0.86 g/g as determined using sorption isotherm experiments, was chosen for in situ removal of ammonium in the culture of P. multocida B:2 mutant. In shake flask culture, the 10 g/L of Amberlite IRC-86 improved the final viable cell concentration (7.2 x 1010 cfu/mL) by about 11 time higher than that obtained in cultivation without resin (6.6 x 109 cfu/mL). In cultivation using 2 L stirred tank bioreactor with internal column containing Amberlite IRC-86, growth of the mutant was enhanced by 10% as compared to the cultivation without resin, agitated at 500 rpm. The final viable cell obtained in stirred tank bioreactor (1.05 x 1011 cfu/mL) was significantly higher than that obtained in shake flask culture. The use of trehalose as protective agent in freeze drying of P. multocida B:2 mutant cells greatly sustained the cell viability (93-95%). During storage at -30◦C and 4◦C, the freeze dried cells using trehalose was also able to maintain the viability (106-108cfu/mL) up to 6 and 12 month, respectively. The stored viable cells was still effective to be used as attenuated vaccine of P. multocida B:2.
first_indexed 2024-03-06T09:58:55Z
format Thesis
id upm.eprints-68527
institution Universiti Putra Malaysia
language English
last_indexed 2024-03-06T09:58:55Z
publishDate 2017
record_format dspace
spelling upm.eprints-685272019-05-16T04:36:53Z http://psasir.upm.edu.my/id/eprint/68527/ Production of viable cells of gdhA derivative Pasteurella multocida B:2 for use as animal vaccine Oslan, Siti Nur Hazwani The attenuated strain of gdhA derivative Pasteurella multocida B:2 (mutant) has demonstrated its efficacy as a live vaccine to control haemorrhagic septicaemia (HS) disease in cattle and buffaloes. However, the commercial application of this vaccine to control HS still faces some limitations such as cost effectiveness of large scale cultivation process, low cell viability and productivity, and unsuitable commercial formulation in order to sustain the cell viability of the bacterial cells in live vaccine. The main objective of this study are to develop the bioprocessing method to increase viability in terms of productivity of gdhA derivative P. multocida B:2 with minimum production cost and to develop essential formulation in powderised form with high bacterial cell survival rate for subsequent use as animal live cell vaccine. The growth medium with the addition of histidine at a concentration of 20 mM greatly improved the cell viability of P. multocida B:2 mutant in cultivation using YDB as basal medium. During batch cultivation of this mutant, ammonium accumulated in the culture greatly inhibited the growth that reduced the final cell concentration and yield. The possibility of using cation-exchange resin for in situ removal of ammonium accumulated in the culture for the improvement of the cultivation of this mutant was investigated in this study. The ability of cationexchange resins, which included Amberlite IRC-86, Amberlite IR120 H, and Dowex DRG8 H, to selectively adsorbed ammonium was first investigated. Amberlite IRC-86, which has capability on ammonium adsorption with Qmax value of 0.86 g/g as determined using sorption isotherm experiments, was chosen for in situ removal of ammonium in the culture of P. multocida B:2 mutant. In shake flask culture, the 10 g/L of Amberlite IRC-86 improved the final viable cell concentration (7.2 x 1010 cfu/mL) by about 11 time higher than that obtained in cultivation without resin (6.6 x 109 cfu/mL). In cultivation using 2 L stirred tank bioreactor with internal column containing Amberlite IRC-86, growth of the mutant was enhanced by 10% as compared to the cultivation without resin, agitated at 500 rpm. The final viable cell obtained in stirred tank bioreactor (1.05 x 1011 cfu/mL) was significantly higher than that obtained in shake flask culture. The use of trehalose as protective agent in freeze drying of P. multocida B:2 mutant cells greatly sustained the cell viability (93-95%). During storage at -30◦C and 4◦C, the freeze dried cells using trehalose was also able to maintain the viability (106-108cfu/mL) up to 6 and 12 month, respectively. The stored viable cells was still effective to be used as attenuated vaccine of P. multocida B:2. 2017-11 Thesis NonPeerReviewed text en http://psasir.upm.edu.my/id/eprint/68527/1/FBSB%202018%2014%20IR.pdf Oslan, Siti Nur Hazwani (2017) Production of viable cells of gdhA derivative Pasteurella multocida B:2 for use as animal vaccine. Doctoral thesis, Universiti Putra Malaysia. Cells - Morphology Pasteurella multocida Veterinary vaccines
spellingShingle Cells - Morphology
Pasteurella multocida
Veterinary vaccines
Oslan, Siti Nur Hazwani
Production of viable cells of gdhA derivative Pasteurella multocida B:2 for use as animal vaccine
title Production of viable cells of gdhA derivative Pasteurella multocida B:2 for use as animal vaccine
title_full Production of viable cells of gdhA derivative Pasteurella multocida B:2 for use as animal vaccine
title_fullStr Production of viable cells of gdhA derivative Pasteurella multocida B:2 for use as animal vaccine
title_full_unstemmed Production of viable cells of gdhA derivative Pasteurella multocida B:2 for use as animal vaccine
title_short Production of viable cells of gdhA derivative Pasteurella multocida B:2 for use as animal vaccine
title_sort production of viable cells of gdha derivative pasteurella multocida b 2 for use as animal vaccine
topic Cells - Morphology
Pasteurella multocida
Veterinary vaccines
url http://psasir.upm.edu.my/id/eprint/68527/1/FBSB%202018%2014%20IR.pdf
work_keys_str_mv AT oslansitinurhazwani productionofviablecellsofgdhaderivativepasteurellamultocidab2foruseasanimalvaccine